Fermer le menu


Member of Lyonbiopole


NETRI develops technologies and microfluidic devices that accelerate the discovery and preclinical phases of a compound in development for pharmaceutical companies, CROs and university researchers interested in neurological disorders (Alzheimer's, Parkinson's, Huntington's).

The company offers both Neurofluidics kits and Neuroscope Labs services to improve understanding of the structural and functional mechanisms of neurological disorders. The Neurofluidics devices use high throughput microfluidic devices to explore specific modes of action and provide rodent / human organ on chip disease models. Neuroscope Labs offer expertise services for rapid and reproducible data acquisition on a neurological compound. NETRI's unique expertise and patented microfluidic engineering technologies enable its solutions to be high throughput and physiologically relevant at the network level.


Strategic application domain: Medical Technologies

Application market: Neurology & Mental Health Disorders, Oncology

Type of activity: CRO - Tools - R&D platform, Therapeutics, Pharma or Biotech

Technologies: Screening methods or services

Created on june 11th, 2018 - 12 employees



Batiment DomiLyon, 321 avenue Jean Jaurès 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.